Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Lifeward Ltd. stock logo
LFWD
Lifeward
$0.67
-0.3%
$1.15
$0.50
$4.77
$7.38M0.02806,193 shs545,246 shs
Predictive Oncology Inc. stock logo
POAI
Predictive Oncology
$0.85
+2.1%
$0.97
$0.55
$3.06
$7.59M1.171.94 million shs41,970 shs
ReShape Lifesciences Inc. stock logo
RSLSD
ReShape Lifesciences
$0.00
$2.91
$82.80
$1.90M2.031,362 shs6,500 shs
Tenon Medical, Inc. stock logo
TNON
Tenon Medical
$0.97
-0.6%
$1.05
$0.85
$15.79
$7.48M1.222.52 million shs46,368 shs
10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Lifeward Ltd. stock logo
LFWD
Lifeward
0.00%+0.15%-43.61%-54.35%-81.86%
Predictive Oncology Inc. stock logo
POAI
Predictive Oncology
0.00%+2.66%-10.32%-36.42%-15.64%
ReShape Lifesciences Inc. stock logo
RSLSD
ReShape Lifesciences
0.00%0.00%0.00%0.00%0.00%
Tenon Medical, Inc. stock logo
TNON
Tenon Medical
0.00%+2.53%-4.51%-18.83%+29.02%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Lifeward Ltd. stock logo
LFWD
Lifeward
2.445 of 5 stars
3.54.00.00.00.60.01.3
Predictive Oncology Inc. stock logo
POAI
Predictive Oncology
2.1205 of 5 stars
3.05.00.00.01.30.00.6
ReShape Lifesciences Inc. stock logo
RSLSD
ReShape Lifesciences
N/AN/AN/AN/AN/AN/AN/AN/A
Tenon Medical, Inc. stock logo
TNON
Tenon Medical
1.4155 of 5 stars
3.53.00.00.00.60.00.0
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Lifeward Ltd. stock logo
LFWD
Lifeward
3.00
Buy$9.001,241.28% Upside
Predictive Oncology Inc. stock logo
POAI
Predictive Oncology
2.00
Hold$3.00252.11% Upside
ReShape Lifesciences Inc. stock logo
RSLSD
ReShape Lifesciences
0.00
N/AN/AN/A
Tenon Medical, Inc. stock logo
TNON
Tenon Medical
3.00
Buy$4.67379.12% Upside

Current Analyst Ratings Breakdown

Latest RSLSD, TNON, POAI, and LFWD Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/14/2025
Tenon Medical, Inc. stock logo
TNON
Tenon Medical
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
4/9/2025
Tenon Medical, Inc. stock logo
TNON
Tenon Medical
Alliance Global Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$3.00
(Data available from 7/6/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Lifeward Ltd. stock logo
LFWD
Lifeward
$25.41M0.29N/AN/A$2.14 per share0.31
Predictive Oncology Inc. stock logo
POAI
Predictive Oncology
$1.62M4.70N/AN/A($0.03) per share-28.40
ReShape Lifesciences Inc. stock logo
RSLSD
ReShape Lifesciences
$610K0.00N/A0.08$341.84 per share0.00
Tenon Medical, Inc. stock logo
TNON
Tenon Medical
$3.28M2.25N/AN/A$0.71 per share1.37
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Lifeward Ltd. stock logo
LFWD
Lifeward
-$28.94M-$3.04N/AN/AN/A-108.21%-101.96%-70.49%8/13/2025 (Estimated)
Predictive Oncology Inc. stock logo
POAI
Predictive Oncology
-$12.66M-$3.05N/AN/AN/A-629.68%-671.29%-132.49%8/12/2025 (Estimated)
ReShape Lifesciences Inc. stock logo
RSLSD
ReShape Lifesciences
-$81.15MN/A0.00N/AN/A-668.58%-163.22%-52.10%N/A
Tenon Medical, Inc. stock logo
TNON
Tenon Medical
-$13.67M-$27.23N/AN/A-417.57%-558.92%-129.73%8/11/2025 (Estimated)

Latest RSLSD, TNON, POAI, and LFWD Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/15/2025Q1 2025
Lifeward Ltd. stock logo
LFWD
Lifeward
-$0.33-$0.46-$0.13-$0.46$5.84 million$5.03 million
5/14/2025Q1 2025
Predictive Oncology Inc. stock logo
POAI
Predictive Oncology
-$0.09-$0.32-$0.23-$0.34$1.50 million$0.11 million
5/13/2025Q1 2025
Tenon Medical, Inc. stock logo
TNON
Tenon Medical
-$1.06-$1.01+$0.05-$1.01$0.76 million$0.73 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Lifeward Ltd. stock logo
LFWD
Lifeward
N/AN/AN/AN/AN/A
Predictive Oncology Inc. stock logo
POAI
Predictive Oncology
N/AN/AN/AN/AN/A
ReShape Lifesciences Inc. stock logo
RSLSD
ReShape Lifesciences
N/AN/AN/AN/AN/A
Tenon Medical, Inc. stock logo
TNON
Tenon Medical
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Lifeward Ltd. stock logo
LFWD
Lifeward
N/A
2.18
1.43
Predictive Oncology Inc. stock logo
POAI
Predictive Oncology
N/A
0.76
0.75
ReShape Lifesciences Inc. stock logo
RSLSD
ReShape Lifesciences
0.05
1.17
1.07
Tenon Medical, Inc. stock logo
TNON
Tenon Medical
N/A
5.46
5.19

Institutional Ownership

CompanyInstitutional Ownership
Lifeward Ltd. stock logo
LFWD
Lifeward
26.76%
Predictive Oncology Inc. stock logo
POAI
Predictive Oncology
9.04%
ReShape Lifesciences Inc. stock logo
RSLSD
ReShape Lifesciences
N/A
Tenon Medical, Inc. stock logo
TNON
Tenon Medical
22.74%

Insider Ownership

CompanyInsider Ownership
Lifeward Ltd. stock logo
LFWD
Lifeward
2.70%
Predictive Oncology Inc. stock logo
POAI
Predictive Oncology
3.44%
ReShape Lifesciences Inc. stock logo
RSLSD
ReShape Lifesciences
N/A
Tenon Medical, Inc. stock logo
TNON
Tenon Medical
0.33%
CompanyEmployeesShares OutstandingFree FloatOptionable
Lifeward Ltd. stock logo
LFWD
Lifeward
6011.01 million10.71 millionOptionable
Predictive Oncology Inc. stock logo
POAI
Predictive Oncology
308.93 million8.63 millionNot Optionable
ReShape Lifesciences Inc. stock logo
RSLSD
ReShape Lifesciences
50354,000N/ANot Optionable
Tenon Medical, Inc. stock logo
TNON
Tenon Medical
87.59 million7.57 millionNot Optionable

Recent News About These Companies

Tenon Medical initiated with a Buy at Alliance Global Partners
Tenon Medical files to sell 5.67M shares of common stock for holders
Tenon gets FDA clearance for Catamaran SI Joint Fusion System indication
Tenon Medical prices $2.5M registered direct offering at $2.00

New MarketBeat Followers Over Time

Media Sentiment Over Time

Lifeward stock logo

Lifeward NASDAQ:LFWD

$0.67 0.00 (-0.25%)
Closing price 07/3/2025 03:58 PM Eastern
Extended Trading
$0.67 +0.00 (+0.45%)
As of 07/3/2025 04:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke. The company markets and sells its products directly to institutions and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Illit, Israel.

Predictive Oncology stock logo

Predictive Oncology NASDAQ:POAI

$0.85 +0.02 (+2.12%)
As of 07/3/2025 03:58 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Predictive Oncology Inc. operates as a science-driven company on the oncology drug discovery. It provides various solutions for the oncology drug development. The company, through the integration of scientific rigor and machine learning, has developed the ability to advance molecules into medicine by introducing human diversity earlier into the discovery process with the pairing of artificial intelligence and the biobank of approximately 150K tumor samples. It operates through four segments: Helomics, zPREDICTA, Soluble, and Skyline. The Helomics segment provides services that include the application of AI, collaboration projects, and clinical testing. The zPREDICTA segment develops organ-specific disease models that provide 3D reconstruction of human tissues representing each disease state and mimicking drug response for testing of anticancer agents. The Soluble segment provides services using a self-contained automated system that conducts self-interaction chromatography screens using additives and excipients included in protein formulations resulting in soluble and physically stable formulations for biologics. This segment also offers protein stability analysis services; protein solubility kits that allow rapid identification of soluble formulations; and proprietary technologies for bacterial endotoxin detection and removal. The Skyline segment provides STREAMWAY System, a wall-mounted fully automated system, which virtually eliminates exposure to blood, irrigation fluid, and other infectious fluids found in the healthcare environment. The company was formerly known as Precision Therapeutics Inc. and changed its name to Predictive Oncology Inc. in June 2019. Predictive Oncology Inc. was incorporated in 2002 and is headquartered in Eagan, Minnesota.

ReShape Lifesciences stock logo

ReShape Lifesciences OTCMKTS:RSLSD

ReShape Lifesciences Inc., a medical device company, focuses on the design, development, and commercialization of technology to treat obesity, metabolic diseases, and other gastrointestinal disorders. The company's product portfolio includes ReShape vBloc, a therapy that enables patients to feel full and eat less by intermittently blocking hunger signals on the vagus nerve; ReShape Vest system, an investigational, minimally invasive, laparoscopically implanted medical device that wraps around the stomach to enable weight loss in obese and morbidly obese patients without permanently changing patient anatomy; and Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy. The company was formerly known as EnteroMedics Inc. and changed its name to ReShape Lifesciences Inc. in October 2017. ReShape Lifesciences Inc. was founded in 2002 and is headquartered in San Clemente, California.

Tenon Medical stock logo

Tenon Medical NASDAQ:TNON

$0.97 -0.01 (-0.63%)
Closing price 07/3/2025 03:58 PM Eastern
Extended Trading
$0.98 +0.00 (+0.41%)
As of 07/3/2025 04:37 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Tenon Medical, Inc., a medical device company, engages in the development of surgical implant systems to treat severe lower back pain in the United States and Puerto Rico. The company offers CATAMARAN SI-Joint Fusion System to fuse sacroiliac joints (SI-Joints) to treat SI-Joint dysfunction that often causes severe lower back pain; and features fixation device that passes through the axial and sagittal planes of the ilium and sacrum, as well as transfixes the SI joints. Tenon Medical, Inc. was incorporated in 2012 and is headquartered in Los Gatos, California.